Anavex Life Sciences (AVXL) Current Ratio: History & Chart

Anavex Life Sciences Corp.(AVXL)

Biotechnology · New York City, NY

$1.60-0.04 (-2.74%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Anavex Life Sciences Corp.

Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's disease and is being explored in preclinical studies for a wider range of disorders, including epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. Another significant drug candidate, ANAVEX 3-71, has progressed to Phase I clinical trials for frontotemporal dementia and other forms of dementia, with additional preclinical investigation underway for neurodegenerative illnesses like Alzheimer's and Parkinson's. The company's earlier-stage portfolio includes ANAVEX 1-41, a sigma-1 receptor agonist targeting depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand with potential applications in neuropathic and visceral pain; and ANAVEX 1037, aimed at treating prostate and pancreatic cancers. Anavex Life Sciences Corp. was founded in 2004 and maintains its headquarters in New York, New York.

New York City, NY

34 employees

www.anavex.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Terrie Kellmeyer

View full financials

AVXL Current Ratio Metrics

CURRENT RATIO

15.62

CURRENT RATIO AVG TTM

15.03

CURRENT RATIO AVG 3Y

12.75

CURRENT RATIO AVG 5Y

13.71

CURRENT RATIO AVG 10Y

10.45

CURRENT RATIO AVG 15Y

7.83

CURRENT RATIO AVG 20Y

5.93

CURRENT VS TTM AVG

+3.91%

CURRENT VS 3Y AVG

+22.46%

CURRENT VS 5Y AVG

+13.94%

CURRENT VS 10Y AVG

+49.39%

CURRENT VS 15Y AVG

+99.50%

CURRENT VS 20Y AVG

+163.23%

SECTOR MEDIAN · HEALTHCARE

3.75

median of 874 covered companies

CURRENT VS SECTOR MEDIAN

+316.50%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Anavex Life Sciences Corp. (AVXL)	$148.27M	15.62	15.03	12.75	13.71
Voyager Therapeutics, Inc. (VYGR)vs ›	$148.64M	7.51	6.60	4.97	4.99
Korsana Biosciences, Inc. (KRSA)vs ›	$148.73M	0.82	5.49	4.19	4.20
ALX Oncology Holdings Inc. (ALXO)vs ›	$149.36M	9.71	4.67	6.04	19.74
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$146.62M	2.47	5.27	13.16	16.37
Codexis, Inc. (CDXS)vs ›	$146.28M	3.06	4.00	3.48	4.36
Fortress Biotech, Inc. (FBIOP)vs ›	$146.27M	3.96	1.88	1.73	2.58
Cardiol Therapeutics Inc. (CRDL)vs ›	$151.01M	5.55	4.34	4.83	5.46
NervGen Pharma Corp. Common stock (NGEN)vs ›	$143.84M	1.23	1.14	1.35	4.96
Veraxa Biotech Holding AG (VRXA)vs ›	$152.72M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

CURRENT RATIO

TTM

Anavex Life Sciences Corp. (AVXL)

$148.27M

15.62

15.03

12.75

13.71

Voyager Therapeutics, Inc. (VYGR)vs ›

$148.64M

7.51

6.60

4.97

4.99

Korsana Biosciences, Inc. (KRSA)vs ›

$148.73M

0.82

5.49

4.19

4.20

ALX Oncology Holdings Inc. (ALXO)vs ›

$149.36M

9.71

4.67

6.04

19.74

Acumen Pharmaceuticals, Inc. (ABOS)vs ›

$146.62M

2.47

5.27

13.16

16.37

Codexis, Inc. (CDXS)vs ›

$146.28M

3.06

4.00

3.48

4.36

Fortress Biotech, Inc. (FBIOP)vs ›

$146.27M

3.96

1.88

1.73

2.58

Cardiol Therapeutics Inc. (CRDL)vs ›

$151.01M

5.55

4.34

4.83

5.46

NervGen Pharma Corp. Common stock (NGEN)vs ›

$143.84M

1.23

1.14

1.35

4.96

Veraxa Biotech Holding AG (VRXA)vs ›

$152.72M

N/A

Current Ratio FAQ

What is the current ratio for Anavex Life Sciences Corp. (AVXL)?

The current ratio for AVXL stock is 15.62.

Is Anavex Life Sciences Corp.'s current ratio high or low?

The current ratio of 15.62 is 14% above its 5-year average of 13.71, around the middle of its 5-year range (6.74–20.87).

What is the TTM average current ratio for Anavex Life Sciences Corp. (AVXL)?

The TTM average current ratio for AVXL stock is 15.03.

What is the 3Y average current ratio for Anavex Life Sciences Corp. (AVXL)?

The 3Y average current ratio for AVXL stock is 12.75.

What is the 5Y average current ratio for Anavex Life Sciences Corp. (AVXL)?

The 5Y average current ratio for AVXL stock is 13.71.

What is the 10Y average current ratio for Anavex Life Sciences Corp. (AVXL)?

The 10Y average current ratio for AVXL stock is 10.45.

What is the 15Y average current ratio for Anavex Life Sciences Corp. (AVXL)?

The 15Y average current ratio for AVXL stock is 7.83.

What is the 20Y average current ratio for Anavex Life Sciences Corp. (AVXL)?

The 20Y average current ratio for AVXL stock is 5.93.

DATE	CURRENT RATIO
2026-06-30	15.62
2026-03-31	18.24
2025-12-31	20.87
2025-09-30	11.60
2025-06-30	8.82
2025-03-31	6.74
2024-12-31	9.45
2024-09-30	8.86
2024-06-30	12.04
2024-03-31	15.12
2023-12-31	11.85
2023-09-30	12.32
2023-06-30	14.27
2023-03-31	11.35
2022-12-31	11.20
2022-09-30	14.95
2022-06-30	16.89
2022-03-31	19.86
2021-12-31	14.90
2021-09-30	14.97
2021-06-30	17.95
2021-03-31	10.76
2020-12-31	6.76
2020-09-30	4.73
2020-06-30	4.55
2020-03-31	4.98
2019-12-31	5.75
2019-09-30	5.03
2019-06-30	5.03
2019-03-31	3.23
2018-12-31	4.53
2018-09-30	6.26
2018-06-30	8.33
2018-03-31	7.55
2017-12-31	10.11
2017-09-30	7.75
2017-06-30	17.09
2017-03-31	11.11
2016-12-31	9.71
2016-09-30	2.96
2016-06-30	4.53
2016-03-31	4.98
2015-12-31	5.54
2015-09-30	5.81
2015-06-30	8.03
2015-03-31	4.16
2014-12-31	4.97
2014-09-30	5.10
2014-06-30	4.31
2014-03-31	4.90
2013-12-31	0.08
2013-09-30	0.20
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	0.02
2012-09-30	0.00
2012-06-30	0.01
2012-03-31	0.06
2011-12-31	0.03
2011-09-30	0.15
2011-06-30	0.57
2011-03-31	0.05
2010-12-31	0.83
2010-09-30	0.10
2010-06-30	0.20
2010-03-31	0.05
2009-12-31	0.02
2009-09-30	0.10
2009-06-30	0.21
2009-03-31	0.02
2008-12-31	0.00
2008-09-30	0.00
2008-06-30	0.01
2008-03-31	0.01
2007-12-31	0.12
2007-09-30	0.00
2007-06-30	0.00
2007-03-31	0.07
2006-12-31	0.14
2006-09-30	0.45
2006-06-30	0.67
2006-03-31	0.00
2005-12-31	0.00
2005-09-30	0.04
2005-06-30	0.00
2005-03-31	0.00
2004-12-31	0.00

DATE

CURRENT RATIO

2026-06-30

15.62

2026-03-31

18.24

2025-12-31

20.87

2025-09-30

11.60

2025-06-30

8.82

2025-03-31

6.74

2024-12-31

9.45

2024-09-30

8.86

2024-06-30

12.04

2024-03-31

15.12

2023-12-31

11.85

2023-09-30

12.32

2023-06-30

14.27

2023-03-31

11.35

2022-12-31

11.20

2022-09-30

14.95

2022-06-30

16.89

2022-03-31

19.86

2021-12-31

14.90

2021-09-30

14.97

2021-06-30

17.95

2021-03-31

10.76

2020-12-31

6.76

2020-09-30

4.73

2020-06-30

4.55

2020-03-31

4.98

2019-12-31

5.75

2019-09-30

5.03

2019-06-30

5.03

2019-03-31

3.23

2018-12-31

4.53

2018-09-30

6.26

2018-06-30

8.33

2018-03-31

7.55

2017-12-31

10.11

2017-09-30

7.75

2017-06-30

17.09

2017-03-31

11.11

2016-12-31

9.71

2016-09-30

2.96

2016-06-30

4.53

2016-03-31

4.98

2015-12-31

5.54

2015-09-30

5.81

2015-06-30

8.03

2015-03-31

4.16

2014-12-31

4.97

2014-09-30

5.10

2014-06-30

4.31

2014-03-31

4.90

2013-12-31

0.08

2013-09-30

0.20

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

0.02

2012-09-30

0.00

2012-06-30

0.01

2012-03-31

0.06

2011-12-31

0.03

2011-09-30

0.15

2011-06-30

0.57

2011-03-31

0.05

2010-12-31

0.83

2010-09-30

0.10

2010-06-30

0.20

2010-03-31

0.05

2009-12-31

0.02

2009-09-30

0.10

2009-06-30

0.21

2009-03-31

0.02

2008-12-31

0.00

2008-09-30

0.00

2008-06-30

0.01

2008-03-31

0.01

2007-12-31

0.12

2007-09-30

0.00

2007-06-30

0.00

2007-03-31

0.07

2006-12-31

0.14

2006-09-30

0.45

2006-06-30

0.67

2006-03-31

0.00

2005-12-31

0.00

2005-09-30

0.04

2005-06-30

0.00

2005-03-31

0.00

2004-12-31

0.00

Current Ratio: 15.62

AVXL Current Ratio

AVXL Average Current Ratio Chart

AVXL Current vs Average Current Ratio Chart

AVXL Current Ratio Metrics

AVXL Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

AVXL Current Ratio History

Related Metrics